Dan Watkins
QuietNamed in filings at Mercury Fund
- Board seats filed
- 13
all filings on record
Named in filings at Mercury Fund
all filings on record
last 24 months
from a verified or cited source
| Recourse Biologics | Biotech & pharma | September 2024 | None on file |
| GlycosBio | Biotech & pharma | March 2023 | None on file |
| AskY Therapeutics | Biotech & pharma | December 2022 | None on file |
| DataBased | HR & future of work | August 2021 | None on file |
| Olea Networks | Climate & energy | February 2020 | None on file |
| Benson Hill Biosystems | Food & agriculture | March 2017 | None on file |
| Resonant Therapeutics | Biotech & pharma | October 2015 | None on file |
| Sinopsys Surgical | Medical devices | October 2014 | None on file |
| DNATRIX | Biotech & pharma | October 2014 | None on file |
| Clean Chemistry | Manufacturing & industrials | October 2014 | None on file |
| DEEP IMAGING TECHNOLOGIES | Climate & energy | March 2014 | None on file |
| Illumitex | Manufacturing & industrials | March 2012 | NEA |
| Swift Biosciences | Biotech & pharma | February 2012 | Arboretum Ventures |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Dan Watkins on the board, based on 13 filed seats with a verified or cited source.